– B-Cells and Antibodies as Contributors to Effector Immune Responses in Tuberculosis. Front Immunol. 2021;12:640168.
– The Role of Complement System and the Immune Response to Tuberculosis Infection. Medicina (Kaunas). 2021;57(2):84.
– Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants. Cells. 2021;10(1):78.
– BCG immunomodulation: From the ‘hygiene hypothesis’ to COVID-19. Immunobiology. 2021;226(1):152052.
En la sección: Artículos de revisión, COVID-19, Efemérides, Infectología, Vacunología. Publicado en: . 
